| CTRI Number |
CTRI/2020/07/026522 [Registered on: 13/07/2020] Trial Registered Prospectively |
| Last Modified On: |
14/05/2021 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda Dentistry |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Clinical Study of MNDV toothpaste in Dental Care |
|
Scientific Title of Study
|
An Open Label, Single Arm, Clinical Study to Evaluate Efficacy and Safety of MNDV toothpaste in Dental Care of Healthy Adults. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| MHC/CT/20-21/006 Ver 1.0, dated 15 Feb 2020 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ninad Naik |
| Designation |
Consultant |
| Affiliation |
Atharv Ayurved and Research Centre |
| Address |
Shirode Rd, opp. krishna chowk, kirti nagar, New sanghavi, pimpri chinchwad.
Pune MAHARASHTRA 411027 India |
| Phone |
9422089260 |
| Fax |
|
| Email |
doctorninaad@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Ms Dipika Patil |
| Designation |
Manager |
| Affiliation |
Mprex Healthcare |
| Address |
414, Nisarg Plaza, Bhumkar Nagar, Wakad, Pune 41105
Pune MAHARASHTRA 411057 India |
| Phone |
7709307004 |
| Fax |
|
| Email |
clinical@mprex.in |
|
Details of Contact Person Public Query
|
| Name |
Mr Ashish Nagaonkar |
| Designation |
Partner |
| Affiliation |
M.N.Pharmaceuticals |
| Address |
27,Madhumansion,Old P.B.Road,NIPANI 591237. Belgaum
Belgaum KARNATAKA 591237 India |
| Phone |
7892647421 |
| Fax |
|
| Email |
pharmaceuticals.m.n@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
MN Pharmaceuticals |
| Address |
R. S.NO 51/1B, KLE CBSE CORNER BUDALMUKH ROAD, NIPANI |
| Type of Sponsor |
Pharmaceutical industry-Indian |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Ninad Naik |
Atharv Ayurved and Research Centre |
Shirode Rd, opp. krishna chowk, kirti nagar, new sanghavi, pimpri-chinchwad Pune MAHARASHTRA |
9422089260
doctorninaad@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Lokmanya Medical Research Center |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K056||Periodontal disease, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
MNDV toothpaste |
4 weeks clinical study to evaluate the efficacy and safety of Herbs & More Herbal Dental Paste in dental care of healthy adults |
| Comparator Agent |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
55.00 Year(s) |
| Gender |
Both |
| Details |
Age: 18 to 55 years (both inclusive) at the time of consent.
Sex: Healthy male or non-pregnant/non-lactating females.
Females of Childbearing potential must have a negative urine pregnancy test performed on screening and enrollment visit.
Subjects are in good general health as determined by the Investigator on the basis of medical history.
Subjects having T-VSC reading (total volatile sulphur compounds) of >160 ppb (parts per billion)
Subjects with mild, moderate and severe plaque with plaque index 2-4.
Subjects with mild to moderate gingivitis with modified gingival index 0.1-0.3.
Subjects should be willing to come to the test site without brushing their teeth in the morning.
Subjects should be willing to not to consume anything except water after meal of previous night.
Subjects must be able to understand and provide written informed consent to participate in the study.
Subjects should be willing and able to follow the study directions to participate in the study.
|
|
| ExclusionCriteria |
| Details |
Subjects with orthodontic bands.
Subjects with plaque index of 0, 1 and 5
Subjects with partial removable dentures.
Subjects having tumor(s) of the soft or hard tissues of the oral cavity.
Subjects with advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone)
Subjects having carious lesion which requires immediate restorative treatment.
Subjects having used antibiotics anytime during the last three months prior to entry into the study.
Subjects having participated in any other dental clinical study within last six months prior to entry into the study.
Subjects with dental prophylaxis during the past two weeks prior to baseline examinations.
Subjects with history of allergies to any oral care/personal care consumer products or their ingredients.
Subjects on any prescription medicines that might interfere with the study outcome.
Subjects taking oral contraceptives and other medication based contraceptives.
Pregnant female subjects or female planning to get pregnant during study duration.
Consumption of any medicated sweets, chewing gum, breath fresheners etc. containing antimicrobial agents.
Subjects with diseases or having history that potentially can contribute to oral malodor (e.g. diabetes mellitus, bronchitis, tonsillitis, sinusitis etc.)
Subjects that consume alcohol.
Subjects that smoke cigarette or consume any other form of tobacco.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the effect of test product for reduction in gingivitis (inflammation of gums) & to evaluate gum tightening by dental examination using modified gingival index. |
From baseline to end of study ie day 30. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To evaluate the effect of test product on malodor control using Halimeter.
To evaluate the effect of test product for plaque reduction using plaque index
To evaluate the effect of test product for reduction in gingival bleeding using modified sulcular bleeding index.
To evaluate the effect of test product on carious teeth by visual assessment by dentist.
To evaluate test product efficacy and tolerance via questionnaires as stated in Appendix III & IV.
|
screening visit (Within -30 Days prior to Day 1) and enrollment (Day 1), evaluation (Day 15 ± 2days) and evaluation/end of study (Day 30 ± 2days) |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" |
|
Phase of Trial
|
Phase 1 |
|
Date of First Enrollment (India)
|
13/07/2020 |
| Date of Study Completion (India) |
15/04/2021 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="4" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
Not Published |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Consideration of oral hygiene and the importance of Ayurveda for dental care is time tested. This research is an attempt to evaluate safety and efficacy of dental paste developed by MN pharmaceuticals in dental health. |